If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJH.L Regulatory News (MJH)

  • There is currently no data for MJH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disclosure Regarding Related Party Transactions

23 Feb 2023 11:07

RNS Number : 8723Q
MJ Hudson Group PLC
23 February 2023
 

This announcement contains inside information

 

 

MJ Hudson Group plc

(the "Company", "Group" or "MJ Hudson")

 

Additional Disclosure Regarding Related Party Transactions

 

MJ Hudson Group plc (AIM:MJH) announces that, as part of the broader accounting review currently being undertaken, it has reviewed, and continues to review, the specific circumstances surrounding certain related party transactions and certain working capital loans taken out by two subsidiaries of the Company.

 

Background

Prior to its IPO on 12 December 2019, the Company had historically used short term working capital loans from a variety of loan providers to support its cash flow, and £1.2 million of these loans remained outstanding at the end of June 2020 ("FY 20"), as disclosed in the notes to the FY 20 accounts. As a result of the review being undertaken, the Board now understands that a number of these working capital loans had been personally guaranteed by the then CEO, Matthew Hudson, and for which guarantees, HCO Global Limited ("HCO Global"), a personal consultancy company and family office owned by Mr Hudson and his wife, charged a sum of £18,763, with such sum included in the FY 20 accounts.

 

These working capital loans were paid back over the course of the financial year ending 30 June 2021 ("FY 21") following receipt of the April 2021 senior loan facility ("Loan Facility") and the FY 21 accounts noted that at the date of the signature of the accounts these had all been fully repaid. It is now understood that Mr Hudson provided personal guarantees in respect of a number of the repaid short term working capital loans, for which HCO Global charged a sum of £61,399 over the year ended June 21, which sum was included in the total paid to HCO Global in the section on related party transactions in the FY 21 accounts.

 

As the terms of the Loan Facility restricted the level of any additional borrowings, no further significant working capital loans were expected. However, between November 2021 and June 2022, a further twelve working capital loans were entered into by two Group subsidiaries, with approximately £1.5 million outstanding at the end of June 2022, and with a number of these further working capital loans personally guaranteed by Mr Hudson. HCO Global charged a further £13,202 during the year. None of the working capital loans in the two Group subsidiaries during this period was brought to the attention of the Board or the Company's Audit and Risk Committee or to the attention of its senior lender until late 2022.

 

Since 30 June 2022, further working capital loans were entered into by the same two Group subsidiaries with an aggregate amount of circa £1.2 million. The aggregate amount currently outstanding under the working capital loans as of 31 January 2023 is £970,000. The Company is in discussion with the relevant loan providers in order to agree future repayment arrangements. No fees were charged by HCO Global post June 2022.

 

Related Party Transactions

While the FY 20 and FY 21 Accounts disclosed the aggregate payments to HCO Global and the related party connection, the nature of the transactions that led to these payments was not disclosed to the Board or set out in the Accounts. The provision of personal guarantees by Mr Hudson in relation to a number of the working capital loans, and the receipt of payments by HCO Global in respect thereof, would likely have been treated as related party transactions under the AIM Rules for Companies requiring disclosure at the time.

 

In addition, and as part of the Board's ongoing review, the Board has taken note that invoices in the amount of £166,430 were raised by HCO Global and paid by the Company for "services in relation to fundraising support for MJ Hudson IPO". Although later noted in the FY 20 accounts as part of an aggregate disclosure of payments during the year to HCO Global and the related party nature, as these related to work undertaken pre-Admission, the Board considers that these payments and any contract relating to them should have been brought to the attention of the Board and the Nominated Adviser and disclosed in the Admission Document as a related party transaction.

 

Under AIM Rule 13, the Board is required to consider, having consulted with its Nominated Adviser, whether the terms of related party transactions are fair and reasonable in so far as shareholders are concerned. Given that the Board and its advisers continue their accounting review, the Directors cannot confirm, and Cenkos cannot advise the Board, that the personal guarantees or the HCO Global payments were fair and reasonable.

 

For further information, please contact:

 

MJ Hudson Group plc +44 20 3463 3200

 

Geoff Miller, Executive Chairman

 

 

Cenkos Securities plc (Nomad and Broker) +44 20 7397 8900

 

Giles Balleny

Stephen Keys

Callum Davidson

 

Buchanan (PR Adviser) +44 20 7466 5000

 

Chris Lane

Jack Devoy

George Cleary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBBGDDLGDDGXX
Date   Source Headline
2nd Jun 20218:00 amRNSChange of Adviser
13th May 202112:19 pmRNSSIP and PDMR Dealings
12th May 20217:00 amRNSPDMR Dealing
10th May 20211:17 pmRNSPDMR Dealings
7th May 202111:36 amRNSRepayment of Director Loan
29th Apr 202111:49 amRNSEmployee Benefit Trust Share Purchases
14th Apr 202110:37 amRNSPDMR Dealing
14th Apr 20217:00 amRNSESG Partnership with MUFG
14th Apr 20217:00 amRNSSenior Debt Facility
8th Apr 20217:00 amRNSEstablishment of Share Incentive Plan
30th Mar 202112:48 pmRNSPDMR Dealing
23rd Mar 20217:00 amRNSInterim Results
16th Mar 20217:00 amRNSInvestor Presentation and Q&A
1st Mar 20217:00 amRNSLaw firm bolstered with senior hires
23rd Feb 20217:00 amRNSNotice of Results
16th Feb 202110:52 amRNSExercise of Options & PDMR Dealing
15th Feb 20213:55 pmRNSIssue of Equity
15th Feb 20217:00 amRNSAcquisition update
11th Feb 20212:11 pmRNSNotification of Major Holdings
8th Feb 20217:00 amRNSGrant of Options & PDMR Interests
3rd Feb 20217:00 amRNSInterim Trading Update
20th Jan 20217:00 amRNSExtension of director loan
5th Jan 20213:00 pmRNSIssue of Equity
30th Dec 20207:00 amRNSAcquisition
10th Dec 20204:32 pmRNSResult of AGM
18th Nov 20209:00 amRNSAnnual Report and Additional Disclosure
23rd Oct 202010:33 amRNSIssue of Equity
21st Oct 20204:53 pmRNSDirector/PDMR Shareholding
19th Oct 20204:04 pmRNSPDMR Dealings
16th Oct 202010:15 amRNSReplacement - Director/PDMR Shareholding
15th Oct 20201:10 pmRNSDirector/PDMR Shareholding
14th Oct 202011:02 amRNSPreliminary Results - Replacement
14th Oct 20207:00 amRNSAcquisition of Bridge Consulting
14th Oct 20207:00 amRNSPreliminary Results
7th Oct 20207:00 amRNSNotice of Results
30th Sep 202010:55 amRNSHolding(s) in Company
29th Sep 20207:00 amRNSAppointment of joint broker
28th Sep 20203:47 pmRNSIssue of Equity
11th Sep 20205:14 pmRNSHolding(s) in Company
1st Sep 202010:45 amRNSEBT Share Purchases
26th Aug 20207:00 amRNSEBT Purchase
19th Aug 20204:46 pmRNSHolding(s) in Company
30th Jul 20203:41 pmRNSEBT Purchase & PCA Dealings
27th Jul 20201:46 pmRNSHolding(s) in Company
24th Jul 20207:00 amRNSEBT Share Purchases
21st Jul 20207:00 amRNSEBT Share Purchases
20th Jul 20207:00 amRNSTrading Statement
17th Jul 20207:00 amRNSShare Purchases by EBT
16th Jul 20207:00 amRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSShare Purchases by EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.